Clinical Trials Directory

Trials / Completed

CompletedNCT00724633

Effect of Lowering the Dialysate Sodium on Blood Pressure in Hemodialysis Patients

Effect of Lowering the Dialysate Sodium on Blood Pressure in Hemodialysis Patients: a Randomized Controlled Trial.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
35 (actual)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients currently receiving hemodialysis will be randomized to receive 1 of 3 dialysate sodium prescriptions. The effects on blood pressure, interdialytic weight gain, thirst, and intradialytic symptoms will be assessed.

Conditions

Interventions

TypeNameDescription
OTHERLowering the dialysate sodiumPlease see above

Timeline

Start date
2011-11-01
Primary completion
2017-06-06
Completion
2017-07-31
First posted
2008-07-29
Last updated
2017-11-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00724633. Inclusion in this directory is not an endorsement.